Table 1 Distributions of clinical and demographic parameters of the study population.

From: Early and Quantitative Assessment of Myocardial Deformation in Essential Hypertension Patients by Using Cardiovascular Magnetic Resonance Feature Tracking

 

Hypertensivepatients (n = 57)

Healthy group (n = 26)

P value

Age (year)

43.04 ± 10.90

38.69 ± 10.44

0.092

Male (%)

35(61.4)

11 (42.3)

0.105

Height (m)

1.68 ± 0.08

1.67 ± 0.07

0.389

Weight (kg)

76.09 ± 14.28

64.81 ± 10.10

<0.001

BMI (kg/m2)

26.74 ± 3.37

23.33 ± 3.06

<0.001

BSA (m2)

1.88 ± 0.21

1.72 ± 0.16

0.001

Clinic SBP (mmHg)

146.11 ± 13.44

110.96 ± 6.00

<0.001

Clinic DBP (mmHg)

92.63 ± 10.29

71.96 ± 4.78

<0.001

MAP (mmHg)

110.46 ± 10.76

84.96 ± 4.84

<0.001

Totalserumcholesterol (mmol/l)

4.56 ± 0.81

4.05 ± 0.66

0.006

Triglycerides (mmol/l)

1.58 (1.13–2.53)

1.33 (1.01–1.64)

0.044

LDL cholesterol (mmol/l)

2.49 ± 0.75

2.14 ± 0.49

0.014

HDL cholesterol (mmol/l)

1.02 ± 0.28

1.35 ± 0.25

<0.001

Hemoglobin A1C (%)

5.74 ± 0.41

5.67 ± 0.35

0.373

Fasting blood glucose(mmol/l)

4.68 ± 0.56

4.76 ± 0.43

0.490

Heart rate (beats/min)

72.73 ± 9.90

68.35 ± 7.90

0.051